CompaniesMetastatix

Metastatix

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

27

By Phase

PHASE1: 1

By Status

SUSPENDED: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2006
2007
2008
2009
2010
Today
NCT00591682
Hover over trial bars to see details

Recent Trials

NCT00591682Lead Sponsor
MSX-122 Administered Orally in Patients With Refractory Metastatic or Locally Advanced Solid Tumors
PHASE1Suspended
27 participants
Started: Nov 30, 2007 · Completed: Mar 31, 2009